Aridis Pharmaceuticals, Inc. (NASDAQ:ARDS – Get Free Report) was the recipient of a significant increase in short interest in the month of June. As of June 30th, there was short interest totalling 2,000,000 shares, an increase of 8.1% from the June 15th total of 1,850,000 shares. Based on an average daily trading volume, of 3,360,000 […]
Aridis Pharmaceuticals, Inc. (NASDAQ:ARDS – Get Free Report) was the recipient of a significant increase in short interest in the month of June. As of June 30th, there was short interest totalling 2,000,000 shares, an increase of 8.1% from the June 15th total of 1,850,000 shares. Based on an average daily volume of 3,360,000 shares, […]
Aridis Receives Agreement from the European Medicines Agency (EMA) on the Clinical Study Design and a Single Confirmatory Phase 3 Study of AR-301 itbusinessnet.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from itbusinessnet.com Daily Mail and Mail on Sunday newspapers.